February 20, 2025

Hospital Occupancy to Reach 85% by 2035

The projection is driven by a decline in staffed beds and an aging population.

Conexiant

February 19, 2025

Hospital Occupancy to Reach 85% by 2035

The projection is driven by a decline in staffed beds and an aging population.

Conexiant

February 18, 2025

FDA Clears Aptima SARS-CoV-2 Assay for High-Throughput Testing

FDA grants 510(k) clearance for Hologic’s Aptima SARS-CoV-2 assay, which uses the Panther system for high-throughput RNA detection.

Conexiant

February 14, 2025

New Blood-Clotting Disorder Linked to Antibodies

Scientists have identified a chronic blood-clotting condition characterized by treatment-resistant thrombosis and linked to monoclonal antibodies targeting platelet factor 4, according to a new study.

Conexiant

February 14, 2025

Study: Patients Trust Female Docs Less

Study findings and an interview with the lead investigator.

Conexiant

February 05, 2025

FDA Approves Tocilizumab Biosimilar

FDA approves AVTOZMA after phase III trial confirms equivalence in efficacy, safety, and pharmacokinetics for RA and other inflammatory conditions.

Conexiant

February 05, 2025

New Study Explores COVID-19’s Dermatologic Impact

More than 20% of COVID-19 patients experience skin conditions, ranging from rashes to pseudochilblains, linked to immune response.

Conexiant

February 03, 2025

U.S. COVID Cases Drop, Pfizer Outlook Shifts

“I'm sort of waiting for another variant to come out of left field. But it hasn’t happened yet.”

Reuters

February 03, 2025

FDA Monthly Round-Up: Key January Updates

January's FDA approvals include therapeutic advancements across neurology, oncology, pain management, and more.

Conexiant